Evidence map›Paper›PMID 30114388›Full record

ArticleBiochemical pharmacology2018

Kinetic mechanism of time-dependent inhibition of CYP2D6 by 3,4-methylenedioxymethamphetamine (MDMA): Functional heterogeneity of the enzyme and the reversibility of its inactivation.

John T Rodgers, Nadezhda Y Davydova, Erickson M Paragas, Jeffrey P Jones, Dmitri R Davydov

Abstract read
In one paragraph

Article in Biochemical pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Inhibitory Effects ofPharmaceutics · 2021
    Article
  6. Numerical Methods for Modeling Enzyme Kinetics.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  7. Irreversible Enzyme Inhibition Kinetics and Drug-Drug Interactions.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Numerical Analysis of Time-Dependent Inhibition by MDMA.Drug metabolism and disposition: the biological fate of chemicals · 2020
    Article
  13. Frontiers in pharmacology · 2020
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

John T RodgersDepartment of Chemistry, Washington State University, Pullman, WA 99164, USA.
Nadezhda Y DavydovaDepartment of Chemistry, Washington State University, Pullman, WA 99164, USA.
Erickson M ParagasDepartment of Chemistry, Washington State University, Pullman, WA 99164, USA.
Jeffrey P JonesDepartment of Chemistry, Washington State University, Pullman, WA 99164, USA.
Dmitri R DavydovDepartment of Chemistry, Washington State University, Pullman, WA 99164, USA; Institute of Biomedical Chemistry, 10 Pogodinskaya Str, Moscow 119121, Russia. Electronic address: d.davydov@wsu.edu.
Washington State University · USInstitute of Biomedical Chemistry · RU

Funding

Predicting Intracellular Drug Concentrations In The Presence Of TransportersR01GM104178 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI Kenneth Ray Korzekwa, Swati Nagar · 2013 to 2026
$4.0M
Improving prediction of drug interactions mediated by time-dependent inhibitorsR01GM114369 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI KORZEKWA, KENNETH RAY, NAGAR, SWATI · 2016 to 2023
$3.2M
NIGMS NIH HHS R01 GM104178NIGMS NIH HHS R01 GM114369
6 · The paper itself

Abstract

We investigate the mechanism of time-dependent inhibition (TDI) of human cytochrome P450 2D6 (CYP2D6) by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), one of the most widespread recreational drugs of abuse. In an effort to unravel the kinetic mechanism of the formation of metabolic inhibitory complex (MIC) of CYP2D6 with MDMA-derived carbene we carried out a series of spectrophotometric studies paralleled with registration of the kinetics of time-dependent inhibition (TDI) in CYP2D6-incorporated proteoliposomes. The high amplitude of spectral signal in this system allowed us to characterize the spectral properties of the formed MIC in details and obtain an accurate spectral signature of MIC formation. This information was then used in the studies with CYP2D6-containing microsomes of insect cells (CYP2D6 Supersomes™). Our results demonstrate that in both systems the formation of the ferrous carbene-derived MIC is relatively slow, reversible and is not associated with the accumulation of the ferric carbene intermediate, as takes place in the case of CYP3A4 and podophylotoxin. Furthermore, the limited amplitude of MIC formation suggests that only a fraction (∼50%) of spectrally detectable CYP2D6 in both proteoliposomes and Supersomes participates in the formation of MIC and is therefore involved in the MDMA metabolism. This observation reveals yet another example of a cytochrome P450 that exhibits persistent functional heterogeneity of its population in microsomal membranes. Our study provides a solid methodological background for further mechanistic studies of MIC formation in human liver microsomes and demonstrates that the potency and physiological relevance of MDMA-dependent TDI of CYP2D6 may be overestimated.

Indexed as

Cytochrome P-450 CYP2D6Cytochrome P-450 CYP2D6 InhibitorsDextromethorphanGene Expression Regulation, EnzymologicHumansKineticsMolecular StructureN-Methyl-3,4-methylenedioxyamphetamineSerotonin AgentsCytochrome P-450 CYP2D6Cytochrome P-450 CYP2D6 InhibitorsDextromethorphanN-Methyl-3,4-methylenedioxyamphetamineSerotonin Agents3,4-methylenedioxymethamphetamineCytochrome P450 2D6Mechanism-based inhibitionMethylenedioxyphenyl compoundsTime-dependent inhibition

Identifiers

PMID30114388
PMCPMC6512342
OpenAlexW2885543493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.